TY  - CONF
AU  - Gluvić, Zoran
AU  - Lačković, Milena
AU  - Samardžić, Vladimir
AU  - Tomašević, Ratko
AU  - Pavlović, Aleksandar
AU  - Obradović, Milan
AU  - Zafirović, Sonja
AU  - Mladenović, Violeta
AU  - Radenković, Saša
AU  - Isenović, Esma R.
PY  - 2022
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12035
C3  - 4. Srpski kongres o menopauzi i involutivnom hipoandrogenizmu : Knjiga apstrakata
T1  - Nealkoholna masna bolest jetre: klinički multidisciplinarni pristup- institucionalna adaptacija postojećim Vodičima kliničke prakse
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12035
ER  - 

@conference{
author = "Gluvić, Zoran and Lačković, Milena and Samardžić, Vladimir and Tomašević, Ratko and Pavlović, Aleksandar and Obradović, Milan and Zafirović, Sonja and Mladenović, Violeta and Radenković, Saša and Isenović, Esma R.",
year = "2022",
journal = "4. Srpski kongres o menopauzi i involutivnom hipoandrogenizmu : Knjiga apstrakata",
title = "Nealkoholna masna bolest jetre: klinički multidisciplinarni pristup- institucionalna adaptacija postojećim Vodičima kliničke prakse",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12035"
}

Gluvić, Z., Lačković, M., Samardžić, V., Tomašević, R., Pavlović, A., Obradović, M., Zafirović, S., Mladenović, V., Radenković, S.,& Isenović, E. R.. (2022). Nealkoholna masna bolest jetre: klinički multidisciplinarni pristup- institucionalna adaptacija postojećim Vodičima kliničke prakse. in 4. Srpski kongres o menopauzi i involutivnom hipoandrogenizmu : Knjiga apstrakata.
https://hdl.handle.net/21.15107/rcub_vinar_12035

Gluvić Z, Lačković M, Samardžić V, Tomašević R, Pavlović A, Obradović M, Zafirović S, Mladenović V, Radenković S, Isenović ER. Nealkoholna masna bolest jetre: klinički multidisciplinarni pristup- institucionalna adaptacija postojećim Vodičima kliničke prakse. in 4. Srpski kongres o menopauzi i involutivnom hipoandrogenizmu : Knjiga apstrakata. 2022;.
https://hdl.handle.net/21.15107/rcub_vinar_12035 .

Gluvić, Zoran, Lačković, Milena, Samardžić, Vladimir, Tomašević, Ratko, Pavlović, Aleksandar, Obradović, Milan, Zafirović, Sonja, Mladenović, Violeta, Radenković, Saša, Isenović, Esma R., "Nealkoholna masna bolest jetre: klinički multidisciplinarni pristup- institucionalna adaptacija postojećim Vodičima kliničke prakse" in 4. Srpski kongres o menopauzi i involutivnom hipoandrogenizmu : Knjiga apstrakata (2022),
https://hdl.handle.net/21.15107/rcub_vinar_12035 .

TY  - JOUR
AU  - Gluvić, Zoran
AU  - Lacković, Milena
AU  - Samardžić, Vladimir
AU  - Mitrović, Bojan
AU  - Mladenović, Violeta
AU  - Obradović, Milan
AU  - Jevremović, Danimir
AU  - Isenović, Esma R.
PY  - 2019
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12027
AB  - Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder with mutations in genes involved in cortisol and aldosterone production. Based on overall 21-OHase activity, CAH is divided into classic (C-CAH) and non-classic (NC-CAH). Females who suffered from NC-CAH have had increased infertility rates and higher miscarriage susceptibility. The treatment of CAH in pregnancy is still debatable. We present 22-years-old pregnant female (seventh week of gestation), who is currently under dexamethasone (DEX) since almost seven years for NC-CAH. At presentation, she is normotensive, non-obese, with no signs of hirsutism and Cushing syndrome. Seven days after the first visit, an endocrinologist makes informative talk with the patient and her mother about NC-CAH, pregnancy, and drugsassociated risks. Current Clinical Practice Guideline for CAH treatment suggests the use of protocols approved by Institutional Review Boards at Centers experienced in CAH treatment. In women with CAH who are planning a pregnancy, a close relationship between endocrinologist, reproductive gynaecologist and molecular biologist is of great interest. Prenatal management with DEX is advised in particular circumstances. In remaining, the switch from DEX to other glucocorticoids that do not penetrate placenta is advised
T2  - Clinical Medical Reviews and Case Reports
T1  - Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report
VL  - 6
IS  - 2
DO  - 10.23937/2378-3656/1410257
ER  - 

@article{
author = "Gluvić, Zoran and Lacković, Milena and Samardžić, Vladimir and Mitrović, Bojan and Mladenović, Violeta and Obradović, Milan and Jevremović, Danimir and Isenović, Esma R.",
year = "2019",
abstract = "Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder with mutations in genes involved in cortisol and aldosterone production. Based on overall 21-OHase activity, CAH is divided into classic (C-CAH) and non-classic (NC-CAH). Females who suffered from NC-CAH have had increased infertility rates and higher miscarriage susceptibility. The treatment of CAH in pregnancy is still debatable. We present 22-years-old pregnant female (seventh week of gestation), who is currently under dexamethasone (DEX) since almost seven years for NC-CAH. At presentation, she is normotensive, non-obese, with no signs of hirsutism and Cushing syndrome. Seven days after the first visit, an endocrinologist makes informative talk with the patient and her mother about NC-CAH, pregnancy, and drugsassociated risks. Current Clinical Practice Guideline for CAH treatment suggests the use of protocols approved by Institutional Review Boards at Centers experienced in CAH treatment. In women with CAH who are planning a pregnancy, a close relationship between endocrinologist, reproductive gynaecologist and molecular biologist is of great interest. Prenatal management with DEX is advised in particular circumstances. In remaining, the switch from DEX to other glucocorticoids that do not penetrate placenta is advised",
journal = "Clinical Medical Reviews and Case Reports",
title = "Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report",
volume = "6",
number = "2",
doi = "10.23937/2378-3656/1410257"
}

Gluvić, Z., Lacković, M., Samardžić, V., Mitrović, B., Mladenović, V., Obradović, M., Jevremović, D.,& Isenović, E. R.. (2019). Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report. in Clinical Medical Reviews and Case Reports, 6(2).
https://doi.org/10.23937/2378-3656/1410257

Gluvić Z, Lacković M, Samardžić V, Mitrović B, Mladenović V, Obradović M, Jevremović D, Isenović ER. Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report. in Clinical Medical Reviews and Case Reports. 2019;6(2).
doi:10.23937/2378-3656/1410257 .

Gluvić, Zoran, Lacković, Milena, Samardžić, Vladimir, Mitrović, Bojan, Mladenović, Violeta, Obradović, Milan, Jevremović, Danimir, Isenović, Esma R., "Management of Non-Classic Congenital Adrenal Hyperplasia in Pregnant Woman - Non-Referral Center Experience- Case Report" in Clinical Medical Reviews and Case Reports, 6, no. 2 (2019),
https://doi.org/10.23937/2378-3656/1410257 . .

TY  - JOUR
AU  - Gluvić, Zoran
AU  - Samardžić, Vladimir
AU  - Zarić, Božidarka
AU  - Đurković, Veslinka
AU  - Mladenović, Violeta
AU  - Stojanović, Marko
AU  - Isenović, Esma R.
PY  - 2017
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12032
AB  - Congenital adrenal hyperplasia (CAH) is a rare genetic disorder which is caused by autosomal recessive mutations in genes, encoding enzymes involved in the process of glyco- and/ or the mineralocorticoid synthesis. It is most common 21-hydroxylase deficiency. Renal disease in patients with CAH is not common but is usually associated with hypertension. Here we present the case of hypotensive terminal chronic renal diseases, which required the support of hemodialysis in patients with noncompliance CAH intermediation with a loss of salt. Also, we analyzed the influence of hemodialysis treatment on biochemical indicators of quality of CAH treatment.
AB  - Kongenitalna adrenalna hiperplazija (KAH) je redak genetski poremećaj, koji je uzrokovan autozomno recesivnom mutacijom gena, koji enkodiraju enzime uključene u procesu glikoi/ili mineralokortikoidne sinteze. Najčešće se javlja deficit 21-hidroksilaze. Bubrežna bolest kod obolelih od KAH nije česta, a obično se povezuje sa hipertenzijom. Prikazuje se slučaj hipotenzivne terminalne hronične bubrežne bolesti, koja je zahtevala hemodijaliznu potporu kod nekomplijantnog bolesnika sa KAH sa gubitkom soli. Takođe, prikazan je uticaj hemodijaliznog tretmana na biohemijske pokazatelje kvaliteta tretmana KAH.
T2  - Medical investigation
T1  - Terminal chronic kidney disease with arterial hypotension in a patient with classic congenital adrenal hyperplasia
T1  - Terminalna hronična bolest bubrega sa arterijskom hipotenzijom kod obolelog od klasične kongenitalne adrenalne hiperplazije
VL  - 51
IS  - 3
SP  - 29
EP  - 33
DO  - 10.5937/MedIst1703029G
ER  - 

@article{
author = "Gluvić, Zoran and Samardžić, Vladimir and Zarić, Božidarka and Đurković, Veslinka and Mladenović, Violeta and Stojanović, Marko and Isenović, Esma R.",
year = "2017",
abstract = "Congenital adrenal hyperplasia (CAH) is a rare genetic disorder which is caused by autosomal recessive mutations in genes, encoding enzymes involved in the process of glyco- and/ or the mineralocorticoid synthesis. It is most common 21-hydroxylase deficiency. Renal disease in patients with CAH is not common but is usually associated with hypertension. Here we present the case of hypotensive terminal chronic renal diseases, which required the support of hemodialysis in patients with noncompliance CAH intermediation with a loss of salt. Also, we analyzed the influence of hemodialysis treatment on biochemical indicators of quality of CAH treatment., Kongenitalna adrenalna hiperplazija (KAH) je redak genetski poremećaj, koji je uzrokovan autozomno recesivnom mutacijom gena, koji enkodiraju enzime uključene u procesu glikoi/ili mineralokortikoidne sinteze. Najčešće se javlja deficit 21-hidroksilaze. Bubrežna bolest kod obolelih od KAH nije česta, a obično se povezuje sa hipertenzijom. Prikazuje se slučaj hipotenzivne terminalne hronične bubrežne bolesti, koja je zahtevala hemodijaliznu potporu kod nekomplijantnog bolesnika sa KAH sa gubitkom soli. Takođe, prikazan je uticaj hemodijaliznog tretmana na biohemijske pokazatelje kvaliteta tretmana KAH.",
journal = "Medical investigation",
title = "Terminal chronic kidney disease with arterial hypotension in a patient with classic congenital adrenal hyperplasia, Terminalna hronična bolest bubrega sa arterijskom hipotenzijom kod obolelog od klasične kongenitalne adrenalne hiperplazije",
volume = "51",
number = "3",
pages = "29-33",
doi = "10.5937/MedIst1703029G"
}

Gluvić, Z., Samardžić, V., Zarić, B., Đurković, V., Mladenović, V., Stojanović, M.,& Isenović, E. R.. (2017). Terminal chronic kidney disease with arterial hypotension in a patient with classic congenital adrenal hyperplasia. in Medical investigation, 51(3), 29-33.
https://doi.org/10.5937/MedIst1703029G

Gluvić Z, Samardžić V, Zarić B, Đurković V, Mladenović V, Stojanović M, Isenović ER. Terminal chronic kidney disease with arterial hypotension in a patient with classic congenital adrenal hyperplasia. in Medical investigation. 2017;51(3):29-33.
doi:10.5937/MedIst1703029G .

Gluvić, Zoran, Samardžić, Vladimir, Zarić, Božidarka, Đurković, Veslinka, Mladenović, Violeta, Stojanović, Marko, Isenović, Esma R., "Terminal chronic kidney disease with arterial hypotension in a patient with classic congenital adrenal hyperplasia" in Medical investigation, 51, no. 3 (2017):29-33,
https://doi.org/10.5937/MedIst1703029G . .